Belančić, A.; Eustaquio, P.C.; Gkrinia, E.M.M.; Rački, V.; Pilipović, K.; Vitezić, D.
Transforming Spinal Muscular Atrophy: From Pivotal Trials to Real-World Evidence and Future Therapeutic Frontiers in Types 1 and 2. Biomedicines 2025, 13, 1939.
https://doi.org/10.3390/biomedicines13081939
AMA Style
Belančić A, Eustaquio PC, Gkrinia EMM, Rački V, Pilipović K, Vitezić D.
Transforming Spinal Muscular Atrophy: From Pivotal Trials to Real-World Evidence and Future Therapeutic Frontiers in Types 1 and 2. Biomedicines. 2025; 13(8):1939.
https://doi.org/10.3390/biomedicines13081939
Chicago/Turabian Style
Belančić, Andrej, Patrick Castillo Eustaquio, Elvira Meni Maria Gkrinia, Valentino Rački, Kristina Pilipović, and Dinko Vitezić.
2025. "Transforming Spinal Muscular Atrophy: From Pivotal Trials to Real-World Evidence and Future Therapeutic Frontiers in Types 1 and 2" Biomedicines 13, no. 8: 1939.
https://doi.org/10.3390/biomedicines13081939
APA Style
Belančić, A., Eustaquio, P. C., Gkrinia, E. M. M., Rački, V., Pilipović, K., & Vitezić, D.
(2025). Transforming Spinal Muscular Atrophy: From Pivotal Trials to Real-World Evidence and Future Therapeutic Frontiers in Types 1 and 2. Biomedicines, 13(8), 1939.
https://doi.org/10.3390/biomedicines13081939
